[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$favQcH4JZUAYm2dhBrVRK8mUvoMK_cosTqzc6VtJM9nw":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":36,"phaseBuckets":42,"rows":49},"Fondazione Don Carlo Gnocchi Onlus",[4],183,false,55,0,332844,2,177,[14,17,20,23,26,29,31,34],{"name":15,"count":16},"Stroke",40,{"name":18,"count":19},"Multiple Sclerosis",28,{"name":21,"count":22},"Parkinson Disease",14,{"name":24,"count":25},"Rehabilitation",10,{"name":27,"count":28},"Chronic Obstructive Pulmonary Disease",4,{"name":30,"count":28},"Stroke Sequelae",{"name":32,"count":33},"Amputation",3,{"name":35,"count":33},"Acquired Brain Injury",[37],{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT04791540","Sarcopenia and Nutritional Status in a Rehabilitation Setting","2025-12-31","Gut microbiota",[43,44,45,46,47,48],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[50,74,92,119,147,173,198],{"intervention":41,"totalTrials":51,"cells":52},1,{"EARLY_PHASE1":53,"PHASE1":55,"PHASE2":57,"PHASE3":59,"PHASE4":61,"NA":63},{"trials":54,"activeCount":9},[],{"trials":56,"activeCount":9},[],{"trials":58,"activeCount":9},[],{"trials":60,"activeCount":9},[],{"trials":62,"activeCount":9},[],{"trials":64,"activeCount":51,"soonestReadout":40},[65],{"nctId":38,"briefTitle":39,"status":66,"phases":67,"primaryCompletion":40,"completion":40,"start":68,"enrollment":69,"conditions":70,"interventions":72},"RECRUITING",[],"2021-06-09",30,[71],"Sarcopenia",[41,73],"Blood Sample",{"intervention":73,"totalTrials":51,"cells":75},{"EARLY_PHASE1":76,"PHASE1":78,"PHASE2":80,"PHASE3":82,"PHASE4":84,"NA":86},{"trials":77,"activeCount":9},[],{"trials":79,"activeCount":9},[],{"trials":81,"activeCount":9},[],{"trials":83,"activeCount":9},[],{"trials":85,"activeCount":9},[],{"trials":87,"activeCount":51,"soonestReadout":40},[88],{"nctId":38,"briefTitle":39,"status":66,"phases":89,"primaryCompletion":40,"completion":40,"start":68,"enrollment":69,"conditions":90,"interventions":91},[],[71],[41,73],{"intervention":93,"totalTrials":51,"cells":94},"epigenetic analyses",{"EARLY_PHASE1":95,"PHASE1":97,"PHASE2":99,"PHASE3":101,"PHASE4":103,"NA":105},{"trials":96,"activeCount":9},[],{"trials":98,"activeCount":9},[],{"trials":100,"activeCount":9},[],{"trials":102,"activeCount":9},[],{"trials":104,"activeCount":9},[],{"trials":106,"activeCount":9},[107],{"nctId":108,"briefTitle":109,"status":110,"phases":111,"primaryCompletion":112,"completion":113,"start":114,"enrollment":115,"conditions":116,"interventions":118},"NCT04766645","ACE2 Gender Differences in Stroke With COVID-19","COMPLETED",[],"2022-12-16","2023-01-31","2020-09-04",77,[117],"Neurologic Manifestations",[93],{"intervention":120,"totalTrials":51,"cells":121},"Genetic analysis of different single nucleotide polymorphisms on ApoE, BDNF and DRD2 genes assessment",{"EARLY_PHASE1":122,"PHASE1":124,"PHASE2":126,"PHASE3":128,"PHASE4":130,"NA":132},{"trials":123,"activeCount":9},[],{"trials":125,"activeCount":9},[],{"trials":127,"activeCount":9},[],{"trials":129,"activeCount":9},[],{"trials":131,"activeCount":9},[],{"trials":133,"activeCount":9},[134],{"nctId":135,"briefTitle":136,"status":137,"phases":138,"primaryCompletion":139,"completion":140,"start":141,"enrollment":142,"conditions":143,"interventions":146},"NCT04495192","Predictors of Better Outcomes After Severe Acquired Brain Injuries","UNKNOWN",[],"2023-06-10","2025-06-10","2020-06-09",520,[144,145],"Brain Injuries","Disorder of Consciousness",[120],{"intervention":148,"totalTrials":51,"cells":149},"Botulinum Toxin+SPRInt",{"EARLY_PHASE1":150,"PHASE1":152,"PHASE2":154,"PHASE3":156,"PHASE4":158,"NA":160},{"trials":151,"activeCount":9},[],{"trials":153,"activeCount":9},[],{"trials":155,"activeCount":9},[],{"trials":157,"activeCount":9},[],{"trials":159,"activeCount":9},[],{"trials":161,"activeCount":9},[162],{"nctId":163,"briefTitle":164,"status":137,"phases":165,"primaryCompletion":166,"completion":167,"start":168,"enrollment":169,"conditions":170,"interventions":172},"NCT03247868","A Multimodal Approach to Cervical Dystonia Treatment With Association of Botulinum Toxin and Motor Learning Techniques",[48],"2018-03-28","2018-06-30","2016-03-16",20,[171],"Cervical Dystonia,Primary",[148],{"intervention":174,"totalTrials":51,"cells":175},"Oxygen Therapy",{"EARLY_PHASE1":176,"PHASE1":178,"PHASE2":180,"PHASE3":182,"PHASE4":184,"NA":186},{"trials":177,"activeCount":9},[],{"trials":179,"activeCount":9},[],{"trials":181,"activeCount":9},[],{"trials":183,"activeCount":9},[],{"trials":185,"activeCount":9},[],{"trials":187,"activeCount":9},[188],{"nctId":189,"briefTitle":190,"status":137,"phases":191,"primaryCompletion":192,"completion":193,"start":194,"enrollment":195,"conditions":196,"interventions":197},"NCT05218564","Air as a Placebo: Increasing the Respiratory Performance of People With COPD Through Simple Expectations of Improvement",[48],"2022-03-30","2022-12-31","2020-02-19",102,[27],[174],{"intervention":199,"totalTrials":51,"cells":200},"BDNF evaluation",{"EARLY_PHASE1":201,"PHASE1":203,"PHASE2":205,"PHASE3":207,"PHASE4":209,"NA":211},{"trials":202,"activeCount":9},[],{"trials":204,"activeCount":9},[],{"trials":206,"activeCount":9},[],{"trials":208,"activeCount":9},[],{"trials":210,"activeCount":9},[],{"trials":212,"activeCount":9},[213],{"nctId":214,"briefTitle":215,"status":137,"phases":216,"primaryCompletion":217,"completion":217,"start":218,"enrollment":69,"conditions":219,"interventions":222},"NCT05735405","Aerobic Exercise and Cognitive Training in Patients With Stroke",[48],"2023-05","2022-11-12",[220,221],"Ischemic Stroke","Hemorrhagic Stroke",[199]]